BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 821271)

  • 1. [An experimental study of the immunogenicity of Pseudomonas aeruginosa vaccines].
    Akatova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1976 May; (5):108-13. PubMed ID: 821271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine].
    Moroz AF; Antsiferova NG; Radkevich SA; Mishina VS
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):74-80. PubMed ID: 6800165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specificity of antimicrobial immunity in experimental infection with strains of Pseudomonas aeruginosa].
    Akatova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):89-93. PubMed ID: 65079
    [No Abstract]   [Full Text] [Related]  

  • 4. [Investigations on the immunogenicity of Pseudomonas seruginosa strains of different serological O-groups].
    Meitert E; Meitert T
    Zentralbl Bakteriol Orig; 1968; 208(4):515-21. PubMed ID: 5000090
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection by vaccination against Pseudomonas infection after thermal injury.
    Markley K; Smallman E
    J Bacteriol; 1968 Oct; 96(4):867-74. PubMed ID: 4971892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes].
    Kholodkova EV; Fedotova IuM; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):47-50. PubMed ID: 2446445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental investigations on the immunogenicity of some Pseudomonas aeruginosa corpuscular vaccines.
    Meitert E; Meitert T; Petrovici M; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):251-66. PubMed ID: 120167
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative experimental study of the immunogenicity of corpuscular vaccines and extracellular antigenic complex of Ps. seruginosa].
    Akatova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1977; (1):30-2. PubMed ID: 65881
    [No Abstract]   [Full Text] [Related]  

  • 9. An acellular vaccine from Pseudomonas aeruginosa: homologous and crossed protection between serogroups according to Habs' classification.
    Berche P; Véron M; Fermanian J; Daoulas-Lebourdelles F; Guégen A
    Ann Microbiol (Paris); 1979; 130(2):179-88. PubMed ID: 90473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective properties of antigenic preparations of Pseudomonas aeruginosa].
    Grishina IA; Kolker II; Stanislavskiĭ ES; Zhvanetskaia MI; Palkina MI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jun; (6):63-7. PubMed ID: 6778029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of early protective responses induced by pseudomonas vaccines.
    Jones RJ
    J Hyg (Lond); 1972 Jun; 70(2):343-51. PubMed ID: 4503873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
    Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA
    Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotyping strains of Pseudomonas aeruginosa].
    Smirnova NE
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Sep; (9):126-9. PubMed ID: 827883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4].
    Nuriddinova NR; Sheremet'ev NN; Ivanova LE; Garib FIu; Iskhakova KhI
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polyvalent Pseudomonas vaccine.
    Sato H; Diena BB
    Rev Can Biol; 1974 Jun; 33(2):93-7. PubMed ID: 4211759
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
    Lieberman MM
    Antibiot Chemother (1971); 1989; 42():193-202. PubMed ID: 2512837
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey).
    Joó I; Stanislavskii ES
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):417-27. PubMed ID: 6819316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines against Pseudomonas aeruginosa infection: 1. Experimental studies.
    Stanislavsky ES; Joo I; Mashilova GM; Boolk VF; Boltutsy LG; Zakgeim DA; Severtśova MK; Yedvabnaya LS; Gladus MA; Fatkhinurova TI
    Vaccine; 1985 Jun; 3(2):128-36. PubMed ID: 3929491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against Pseudomonas aeruginosa: the effects of serotype and virulence in mouse protection tests.
    Markman B; Fall-Persson M; Salenstedt CR
    J Biol Stand; 1982 Oct; 10(4):319-28. PubMed ID: 6818231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.